Aldeyra Therapeutics Enrolls First Patient in Phase 3 Dry Eye Chamber Study-March 2024-www.financetom.com

Aldeyra Therapeutics Enrolls First Patient in Phase 3 Dry Eye Chamber Study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Aldeyra Therapeutics Enrolls First Patient in Phase 3 Dry Eye Chamber Study

May 8, 2024 12:33 PM

03:12 PM EDT, 05/08/2024 (MT Newswires) -- Aldeyra Therapeutics ( ALDX ) said Wednesday the first patient has been enrolled in a phase 3 dry eye chamber trial of reproxalap in dry eye disease.

Reproxalap is an investigational reactive aldehyde species modulator, and the trial is designed to support the resubmission of a new drug application, the company said.

The trial will assess ocular discomfort in patients with dry eye disease, the company said.

Aldeyra expects to resubmit a new drug application for reproxalap to the US Food and Drug Administration for the treatment of dry eye disease in H2.

The company's shares fell 3% in recent trading Wednesday.

Price: 4.05, Change: -0.13, Percent Change: -3.00

Previous page： Soundhound AI Insider Sold Shares Worth $2,216,590, According to a Recent SEC Filing Next page： Atlassian Insider Sold Shares Worth $1,274,785, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Soundhound AI Insider Sold Shares Worth $2,216,590, According to a Recent SEC Filing

Sep 25, 2025

03:47 AM EDT, 09/25/2025 (MT Newswires) -- Keyvan Mohajer, 10% Owner, Director, Chief Executive Officer, on September 22, 2025, sold 138,523 shares in Soundhound AI ( SOUN ) for $2,216,590. Following the Form 4 filing with the SEC, Mohajer has control over a total of 2,461,267 Class A common shares of the company, with 2,461,267 shares held directly. SEC Filing:...

Atlassian Insider Sold Shares Worth $1,274,785, According to a Recent SEC Filing

Sep 25, 2025

03:50 AM EDT, 09/25/2025 (MT Newswires) -- Scott Farquhar, 10% Owner, Director, on September 23, 2025, sold 7,665 shares in Atlassian ( TEAM ) for $1,274,785. Following the Form 4 filing with the SEC, Farquhar has control over a total of 38,325 Class A common shares of the company, with 38,325 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000166612125000030/xslF345X05/primarydocument.xml ...

Soundhound AI Insider Sold Shares Worth $2,098,697, According to a Recent SEC Filing

Sep 25, 2025

03:49 AM EDT, 09/25/2025 (MT Newswires) -- Nitesh Sharan, Chief Financial Officer, on September 22, 2025, sold 126,596 shares in Soundhound AI ( SOUN ) for $2,098,697. Following the Form 4 filing with the SEC, Sharan has control over a total of 1,796,304 Class A common shares of the company, with 1,796,304 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1840856/000191799225000010/xslF345X05/primarydocument.xml ...

Soundhound AI Insider Sold Shares Worth $1,320,232, According to a Recent SEC Filing

Sep 25, 2025

03:48 AM EDT, 09/25/2025 (MT Newswires) -- Majid Emami, 10% Owner, Vice President, Engineering, on September 22, 2025, sold 78,304 shares in Soundhound AI ( SOUN ) for $1,320,232. Following the Form 4 filing with the SEC, Emami has control over a total of 649,353 Class A common shares of the company, with 649,353 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1840856/000192047525000010/xslF345X05/primarydocument.xml...